Should immediate lymphadenectomy be discontinued in patients with metastasis of a melanoma in the sentinel lymph node? Report of the results of the Multicenter Selective Lymphadenectomy Trial-II
Med Clin (Barc). 2018 Apr 23;150(8):323-326.
doi: 10.1016/j.medcli.2017.08.013.
Epub 2017 Oct 28.
[Article in
English,
Spanish]
Affiliations
- 1 Unidad de Melanoma, Servicio de Dermatología, Hospital Clínic, Barcelona, España. Electronic address: dmoreno@e-derma.org.
- 2 Servicio de Medicina Nuclear, Hospital Clínic, Barcelona, España.
- 3 Unidad de Melanoma, Servicio de Dermatología, Hospital Clínic, Barcelona, España.
No abstract available
Publication types
-
Clinical Trial, Phase II
-
Multicenter Study
-
Randomized Controlled Trial
MeSH terms
-
Humans
-
Lymph Node Excision* / methods
-
Lymphatic Metastasis
-
Melanoma / secondary*
-
Melanoma / surgery*
-
Sentinel Lymph Node
-
Skin Neoplasms / pathology*
-
Time Factors